Skip to content

The effects of robotic rehabilitation wearing a Mask due to COVID-19 on cardiopulmonary function, and muscle fatigue in healthy subject and brain damage

The effects of robotic rehabilitation wearing a Mask due to COVID-19 on cardiopulmonary function, and muscle fatigue in healthy subject and brain damage

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006327
Enrollment
30
Registered
2021-07-07
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(robotic rehabilitation with and without mask) : Muscle fatigue using surface electromyography and body temperature through non-contact thermometer for subacute stroke patients and normal people

Sponsors

Yonsei University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) survivors of cortical/subcortical ischemic stroke (2) age between 18 and 99 years; (3) first clinical stroke presentation or prior stroke with no residual deficits affecting ambulation; (4) ability to follow a two-step command; (5) Fugl-Meyer sensory score > 2; (6) clinically assessed to be suitable for gait training (ability to ambulate at least one step with a device/assistance); (7) height, 132–200 cm; (8) hip-knee joint distance, 33–48 cm; and (9) knee joint–foot distance, 33–48 cm.

Exclusion criteria

Exclusion criteria: (1) cerebellar/brainstem stroke survivor; (2) body weight less than 135 kg; (3) uncontrolled hypertension (stage 2) with blood pressure >160/100 mmHg; (4) cardiopulmonary impairments affecting the ambulation test; (5) integumentary impairment, such as skin breakdown or bedsores around the suspension belt loading area; (6) significant and persistent mental illness; (7) a lower extremity fixed contracture or deformity; (8) bone instability (non-consolidated fractures, unstable spinal column, or severe osteoporosis necessitating treatment with bisphosphonates); (9) other neurodegenerative disorders (amyotrophic lateral sclerosis, Parkinson’s disease); (10) MAS score > 3 of the affected leg; (11) significant back or leg pain resulting in an inability to tolerate movement; (12) impaired sensory perception affecting the participant’s ability to distinguish whether the device is fitted correctly; and (13) aphasia, sufficient to prevent them from the ability to communicate discomfort.

Design outcomes

Primary

MeasureTime frame
muscle fatigue, O2 saturation, heart rate, pulse

Secondary

MeasureTime frame
temperature, blood pressure, Borg rating perceived exertion

Countries

Korea, Republic of

Contacts

Public ContactChanhee Park

Yonsei University

chaneesm@gmail.com+82-33-760-2957

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026